| Special Notice |
 ViaMetrics-E™ is not currently cleared for use in the U.S. by the Food and Drug Administration.
|
| ViaMetrics-E™ Technology Animation |
|
| ViaMetrics-E™ Procedure Video |
|
| Your comments ? |
We would like to hear your comments and opinions. Please go to our contact page to
 Post a message |
 |
|
|
Company Renames First Product ViaMetrics-E™:
 Molecular Biometrics has changed the name of its first, groundbreaking product for embryo viability assessment from ViaTest-E™ to ViaMetrics-E™. We look forward to providing additional updates as we move toward product launch.
Healthcare Innovation through Metabolomics™:
Molecular Biometrics, Inc., is applying novel metabolomic technologies to develop accurate, non-invasive methodologies for evaluating normal biologic function in health and disease, and for drug discovery and development. The company’s proprietary technology is being applied in reproductive health, neurodegenerative disease (Alzheimer’s disease and Parkinson’s disease), maternal fetal medicine, pulmonary metabolism and edema, and lactate metabolism.
Click here for Company information |
Recent MB News
Groundbreaking research published in the Journal of Alzheimer’s Disease. Click here for full articleMB receives 2009 Genesis Technology Transfer Award, presented by BIOQuebec. Click here for full articleTo see a list of all recent news Click here
|
 |
|